Pharmaceuticals Company Reports & Industry Analysis
If you’re searching for objective information on top pharmaceutical companies—including emerging and established players—look no further. MarketResearch.com offers a vast collection of reports that provide detailed insights into a company’s organizational structure and key offerings within the pharmaceutical industry. These reports are valuable resources for identifying potential clients and partners, as well as gaining a deeper understanding of the strengths and weaknesses of competitors.
Pharmaceutical Company Profiles
- Access financial analysis, strategic assessments, SWOT analyses, and information on collaboration and licensing deals.
- Gain expert insights on prominent competitors such as Pfizer, Roche, Merck, AstraZeneca, Sanofi, Eli Lilly, and more.
- Browse reports from various research firms such as GlobalData, MarketLine, Current Partnering, Plunkett Research, and many others.
A Reliable Source for Research
Our pharmaceutical company reports provide you with crucial data and insights from leading market research firms around the world. Whether you are conducting due diligence, or looking to expand into new markets, our research delivers the strategic intelligence needed for success. For decades, organizations across the value chain have chosen us as their trusted partner. Browse our reports today for unmatched value and convenience.
Pharmaceuticals Company Reports Industry Research & Market Reports
-
2022 Teva Pharmaceuticals Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... more than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and ... Read More
-
2022 Incyte Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 Vertex Pharmaceuticals Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... more than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and ... Read More
-
2022 Bristol-Myers Squibb Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... more than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and ... Read More
-
2022 Akorn Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 Momenta Pharmaceuticals Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... more than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and ... Read More
-
2022 Exelixis Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 Shire Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 AstraZeneca Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 GlaxoSmithKline Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 Alexion Pharmaceuticals Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... more than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and ... Read More
-
2022 Abbvie Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 Amgen Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 Intercept Pharmaceuticals Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... more than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and ... Read More
-
2022 Endo Pharmaceuticals Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... more than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and ... Read More
-
2022 Valeant Pharmaceuticals Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... more than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and ... Read More
-
2022 Perrigo Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 Bayer Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 Zoetis Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 Jazz Pharmaceuticals Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... more than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and ... Read More
-
2022 Eli Lilly Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... more than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and ... Read More
-
2022 Sanofi Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
2022 Roche Annual Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
... than 1,000 companies worldwide. The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures ... Read More
-
Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
... of Royalty Rates for Pharmaceuticals & Biotechnology continues to focus on the financial terms and royalty rates associated with biotechnology and pharmaceutical intellectual property transfers. This report is a tool that can be used as ... Read More
-
The Market and Future Potential for Molecular Point of Care
... times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a ... Read More
Research Assistance
